Harry Lampiris
Overview
Explore the profile of Harry Lampiris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
2825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chien A, Domeracki S, Guntur S, Taylor K, Lu C, Lampiris H, et al.
J Occup Med Toxicol
. 2021 Aug;
16(1):29.
PMID: 34348733
Objective: Household SARS-COV-2 contact constitutes a high-risk exposure for health care workers (HCWs). Cycle threshold (Ct) of reverse transcriptase-polymerase chain reaction testing provides an estimate of COVID-19 viral load, which...
2.
Domeracki S, Clapp R, Taylor K, Lu C, Lampiris H, Blanc P
J Occup Environ Med
. 2020 Aug;
62(11):889-891.
PMID: 32804748
Objective: To ascertain whether reverse transcriptase polymerase chain reaction (RT-PCR) cycle amplifications until detection, the cycle threshold (Ct), could help inform return to work (RTW) strategies for health care workers...
3.
Ward L, Peluso M, Budak J, Elicker B, Chin-Hong P, Lampiris H, et al.
BMJ Case Rep
. 2020 May;
13(4).
PMID: 32354764
We describe a case of opportunistic coinfections with and following treatment with idelalisib, a phosphoinositide 3-kinase inhibitor, for chronic lymphocytic leukaemia. This is the first case of pulmonary coccidioidomycosis reported...
4.
Budak J, Brickman C, Abdoler E, Wallender E, Mulliken J, Kerkhoff A, et al.
Open Forum Infect Dis
. 2020 Apr;
7(4):ofaa098.
PMID: 32284950
No abstract available.
5.
Ramirez J, Maddali M, Budak J, Li J, Lampiris H, Shah M
J Gen Intern Med
. 2019 Dec;
35(5):1498-1503.
PMID: 31792870
Background: Individualized selection of antiretroviral (ARV) therapy is complex, considering drug resistance, comorbidities, drug-drug interactions, and other factors. HIV-ASSIST (www.hivassist.com) is a free, online tool that provides ARV decision support....
6.
Yukl S, Kaiser P, Kim P, Telwatte S, Joshi S, Vu M, et al.
Sci Transl Med
. 2018 Mar;
10(430).
PMID: 29491188
Latently infected CD4 T cells are the main barrier to complete clearance of HIV infection, but it is unclear what mechanisms govern latent HIV infection in vivo. To address this...
7.
8.
Louie J, Lampiris H
JAMA Intern Med
. 2015 Oct;
175(12):1899-900.
PMID: 26501509
No abstract available.
9.
Greene M, Covinsky K, Valcour V, Miao Y, Madamba J, Lampiris H, et al.
J Acquir Immune Defic Syndr
. 2015 May;
69(2):161-7.
PMID: 26009828
Background: Geriatric syndromes such as falls, frailty, and functional impairment are multifactorial conditions used to identify vulnerable older adults. Limited data exist on these conditions in older HIV-infected adults, and...
10.
Chartier M, Crouch P, Tullis V, Catella S, Frawley E, Filanosky C, et al.
J Int Assoc Provid AIDS Care
. 2014 Dec;
14(3):197-201.
PMID: 25487428
HIV-associated neurocognitive disorders (HANDs) are common, often go undetected, and can impact treatment outcomes. There is limited evidence on how to perform routine cognitive screening in HIV clinical settings. To...